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To the Editor: The recent article 
by Oh et al. (1) discussed the utility 
of email surveys for the investigation 
of outbreaks. After they have been 
created, digital surveys require less 
time to administer than paper-based 
or telephone surveys and can produce 
high-quality and timely data. During an 
outbreak in Illinois, we used email and 
a social networking site to distribute 
a link to a confi dential Inquisit 
(www.millisecond.com) survey and 
compared characteristics of the groups 
that responded to each. 
In December 2010, the Illinois 
Department of Public Health 
received a report of an outbreak of 
gastrointestinal illness among guests 
at a wedding reception. Health 
department staff converted a standard 
foodborne outbreak questionnaire 
to a digital format. The survey link 
was then distributed to guests by 2 
methods: email from the reception 
hosts and the note function on the 
host’s Facebook page. Facebook has 
500 million active users, 50% of whom 
check their Facebook pages every day 
(2). The Facebook note function is a 
blogging feature through which users 
can publish content visible to linked 
friends.
A total of 14 persons responded to 
the email-distributed survey link and 
41 to the Facebook-distributed survey 
link. For each survey, data quality was 
high and response rates for questions 
were >90%. Facebook respondents 
were younger than email respondents 
(mean ages 29.8 and 37.4 years, 
respectively). Information provided 
by Facebook respondents covered 
persons 11 months to 80 years of age 
and by email respondents 1–67 years 
of age. Parents were asked to complete 
surveys for any children unable to 
answer the questions independently. 
The Facebook-distributed survey had a 
higher percentage of male respondents 
(41.5%) than did the email-distributed 
survey (21.4%).
Facebook-distributed surveys were 
answered signifi cantly faster than 
email-distributed surveys (p<0.05). 
The mean number of hours from 
distribution to response was 42.3 
for the email survey and 8.7 for the 
Facebook survey. The Facebook 
survey link was distributed at 6:00 PM 
on a Thursday evening; 34 (82.9%) 
surveys were completed by 9:00 AM on 
Friday morning. On the basis of these 
responses, health department staff 
were able to identify the implicated 
foods the day after the questionnaires 
were distributed.
Distributing foodborne outbreak 
questionnaires through Facebook 
generated data that were complete 
and timely. Facebook-distributed 
surveys captured a wide range of 
respondent age groups and more male 
respondents than did email-distributed 
surveys. Previous studies of online 
survey response rates found rates to be 
signifi cantly higher for women than 
for men (3). In addition to low cost 
and signifi cantly improved survey 
response times, social networking 
distribution holds other advantages 
for health departments. Recall errors 
are reduced by distributing the 
survey to persons simultaneously 
and immediately. Posting of surveys 
through a health department’s social 
networking accounts could also 
enable participation of persons for 
whom the health department does not 
have contact information. Given these 
advantages and the widespread use of 
social networking, use of these tools 
should be considered as an option for 
survey distribution during outbreak 
investigations.
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To the Editor: A measles 
epidemic is currently occurring in 
several countries in Europe (1,2). 
Although most cases concern 
unvaccinated children and young 
adults, health care professionals 
(HCPs) are also affected. Cases occur 
mostly in unvaccinated persons, but 
also in those who have received a 
single dose of vaccine.
In France, the measles vaccine 
was introduced in the childhood-
immunization schedule in 1983. 
Current guidelines recommend 2 
doses: one at 12 months of age and the 
second between 13 and 24 months of 
age. For persons born after 1992, one 
catch-up dose is recommended (3). 
Coverage by >1 dose, by the age of 2 
years, remained at 83%–87% during 
1997–2005. The latest fi gures show a 
slight increase to 90% in 2007 (4).
The risk for measles in HCPs 
has been estimated as 13× higher 
than that for the general population 
(5) and is also higher among students 
(6). Vaccination against measles is 
recommended, not mandatory, for 
HCPs and health care students (HCSs) 
(medicine, nursing, and midwifery) 
who have no history of measles. The 
objective is to prevent transmission 
to a nonimmunized patient or another 
HCP, and from patients to susceptible 
HCPs. HCSs are in close and repeated 
contact with patients and therefore 
targeted by the recommendations. We 
conducted a cross-sectional survey 
in the university hospitals in Paris, 
France, to assess measles vaccination 
coverage in HCSs.
The sampling frame included 15 
hospitals with an obstetrics department. 
All midwifery students were selected. 
Other students were selected through 
a multistage random sampling. 
Sampling units were selected at each 
stage by simple random sampling. 
We selected 10 hospitals at the fi rst 
stage, 10 clinical wards by hospital 
at the second stage, and all nursing 
students and half the medical students 
by ward at the third stage. A total of 
116 students were required from each 
profession to estimate 50% coverage 
with 10% precision.
Students gave oral informed 
consent. Information was collected by 
face-to-face interview. Vaccination-
status was assessed from a document 
when available. Measles vaccination 
coverage was defi ned as the number 
of students with no history of measles 
who had received >1 dose of vaccine 
divided by the total number of students 
with no history of measles. The study 
was approved by the French Ethics 
Board and conducted from March 
2009 through July 2009.
Of the 106 selected wards, 10 
could not be included (clearance 
from the head of department was 
not given). Of the 488 selected 
students, 432 were enrolled in the 
study (participation rate 88.5%); 
178 (41%) were medical students, 
147 (34%) nursing students, and 
107 (25%) midwifery students. A 
document confi rming the student’s 
vaccination status was available for 
376 (87%) students; 38 (10.1%) had 
a history of measles (removed from 
analysis). Median age was 22 years 
(interquartile range 21–24 years); 74% 
were female. Measles vaccination 
was cited by 61.5% (95% confi dence 
interval [CI] 50.0%–71.9%) as a 
recommended vaccination. Measles 
vaccination coverage was 79.3% 
(95% CI 71.0%–75.8%) for >1 dose 
and 49.6% (95% CI 40.3%–59.1%) 
for 2 doses (Table). When considering 
only the students’ accounts (without 
written confi rmation), 1- and 2-dose 
vaccination coverage was 93.3% 
(95% CI 88.0%–96.3%) and 83.6% 
(95% CI 68.0%–92.4%), respectively. 
In multivariate analysis, younger 
students (<22 years of age) were 
more likely to have had 1 dose than 
older students (p<0.001).
In the context of measles 
epidemics affecting France, and 
considering that the World Health 
Organization recommends 95% 
coverage of the population with 2 
doses of a measles vaccine, our study 
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Table. Age, gender ratio, and rates of measles vaccination coverage for health care students, Paris, France* 
Characteristic Medical students, n = 178 Nursing students, n = 147 Midwifery students, n = 107 Total, n = 432 
Median age, y 23 22 22 22
Gender ratio, M:F 0.68 0.09 0.05 0.26
One dose, % (95% CI) 79.9 (67.1–88.6) 85.7 (67.1–88.6) 76.8 (63.1–86.5) 79.3 (71.0–85.8) 
Two doses, % (95% CI) 46.3 (31.2–62.2) 66.9 (55.2–76.8) 55.7 (41.1–69.4) 49.6 (40.3–59.1) 
*CI, confidence interval. 
